Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Glaab T, Vogelmeier C, Buhl R.

Respir Res. 2010 Jun 17;11:79. doi: 10.1186/1465-9921-11-79. Review.

2.

Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease.

Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K.

Int J Chron Obstruct Pulmon Dis. 2011;6:521-6. doi: 10.2147/COPD.S24420. Epub 2011 Oct 11.

3.

Measuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trials.

Leidy NK, Murray LT, Monz BU, Nelsen L, Goldman M, Jones PW, Dansie EJ, Sethi S.

Respir Res. 2014 Oct 7;15:124. doi: 10.1186/s12931-014-0124-z.

4.

Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses.

Rugbjerg M, Iepsen UW, Jørgensen KJ, Lange P.

Int J Chron Obstruct Pulmon Dis. 2015 Apr 17;10:791-801. doi: 10.2147/COPD.S78607. eCollection 2015. Review.

5.

Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.

Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K.

Respir Res. 2012 Sep 25;13:85. doi: 10.1186/1465-9921-13-85.

6.

Screening for severe physical inactivity in chronic obstructive pulmonary disease: the value of simple measures and the validation of two physical activity questionnaires.

DePew ZS, Garofoli AC, Novotny PJ, Benzo RP.

Chron Respir Dis. 2013 Feb;10(1):19-27. doi: 10.1177/1479972312464243. Epub 2012 Nov 13.

PMID:
23149382
7.

Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease.

Roberts MH, Mapel DW, Bruse S, Petersen H, Nyunoya T.

Am J Epidemiol. 2013 Oct 1;178(7):1150-60. doi: 10.1093/aje/kwt087. Epub 2013 Aug 8.

8.

Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?

Ekström M, Sundh J, Larsson K.

Expert Rev Respir Med. 2016;10(3):351-62. doi: 10.1586/17476348.2016.1146595. Epub 2016 Feb 16. Review.

PMID:
26808786
9.

[Therapeutic goals and outcome measurements in COPD patients].

Morr H.

Med Klin (Munich). 2006 Apr 15;101(4):279-82. Review. German.

PMID:
16607483
10.

COPD management: role of symptom assessment in routine clinical practice.

van der Molen T, Miravitlles M, Kocks JW.

Int J Chron Obstruct Pulmon Dis. 2013;8:461-71. doi: 10.2147/COPD.S49392. Epub 2013 Oct 14. Review.

11.

Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients.

Kruis AL, van Adrichem J, Erkelens MR, Scheepers H, In 't Veen H, Muris JW, Chavannes NH.

Int J Chron Obstruct Pulmon Dis. 2010 Nov 25;5:407-13. doi: 10.2147/COPD.S9654.

12.

Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.

Jones RC, Price D, Chavannes NH, Lee AJ, Hyland ME, Ställberg B, Lisspers K, Sundh J, van der Molen T, Tsiligianni I; UNLOCK Group of the IPCRG.

NPJ Prim Care Respir Med. 2016 Apr 7;26:16010. doi: 10.1038/npjpcrm.2016.10.

13.

Minimal clinically important differences in pharmacological trials.

Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA.

Am J Respir Crit Care Med. 2014 Feb 1;189(3):250-5. doi: 10.1164/rccm.201310-1863PP. Review.

PMID:
24383418
14.

Gait speed as a measure of functional status in COPD patients.

Karpman C, Benzo R.

Int J Chron Obstruct Pulmon Dis. 2014 Nov 21;9:1315-20. doi: 10.2147/COPD.S54481. eCollection 2014. Review.

15.

Surrogates of mortality in chronic obstructive pulmonary disease.

Cote CG.

Am J Med. 2006 Oct;119(10 Suppl 1):54-62. Review.

PMID:
16996900
16.

Physical activity in patients with COPD.

Watz H, Waschki B, Meyer T, Magnussen H.

Eur Respir J. 2009 Feb;33(2):262-72. doi: 10.1183/09031936.00024608. Epub 2008 Nov 14. Erratum in: Eur Respir J. 2010 Aug;36(2):462.

17.

High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.

Liu SF, Wang CC, Chin CH, Chen YC, Lin MC.

Arch Bronconeumol. 2011 Sep;47(9):427-32. doi: 10.1016/j.arbres.2011.04.011. Epub 2011 Aug 6. English, Spanish.

18.
19.

Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.

Mok M, Nombela-Franco L, Dumont E, Urena M, DeLarochellière R, Doyle D, Villeneuve J, Côté M, Ribeiro HB, Allende R, Laflamme J, DeLarochellière H, Laflamme L, Amat-Santos I, Pibarot P, Maltais F, Rodés-Cabau J.

JACC Cardiovasc Interv. 2013 Oct;6(10):1072-84. doi: 10.1016/j.jcin.2013.06.008.

20.

Activity restriction in mild COPD: a challenging clinical problem.

O'Donnell DE, Gebke KB.

Int J Chron Obstruct Pulmon Dis. 2014 Jun 4;9:577-88. doi: 10.2147/COPD.S62766. eCollection 2014. Review.

Supplemental Content

Support Center